Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (11 quarters reported)
$179M in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended December 31, 2015. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N Na | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2015 · filed February 10, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust | Exited | −700,000 | −$134M | — |
| IL Ishares Lehman 20+ Yr Treas | Exited | −762,000 | −$94.1M | — |
| IR Ishares Russell 2000 | Exited | −600,000 | −$65.5M | — |
| PC Patterson Cos Inc | Exited | −1,225,000 | −$53M | — |
| E Endologix Inc | Exited | −4,050,000 | −$49.7M | — |
| Medtronic PLC | Exited | −700,000 | −$46.9M | — |
| Quest Diagnostics | Exited | −700,000 | −$43M | — |
| G Greatbatch Inc | Exited | −700,000 | −$39.5M | — |
| BD Becton Dickinson & Co | Exited | −275,000 | −$36.5M | — |
| NM Nxstage Medical Inc | Exited | −2,000,000 | −$31.5M | — |
Showing the 10 largest of 33 changes.
quarter ended September 30, 2015 · filed November 10, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IL Ishares Lehman 20+ Yr Treas | New | +762,000 | +$94.1M | 11.2% |
| SS SPDR S&P 500 ETF Trust | Exited | −400,000 | −$82.3M | — |
| Merck & Co. Inc. | New | +400,000 | +$19.8M | 2.4% |
| SS SPDR S&P 500 ETF Trust | Added | +100,000 | +$19.2M | 16.0% |
| BD Becton Dickinson & Co | Trimmed | −125,000 | −$16.6M | 4.3% |
| PC Patterson Cos Inc | Added | +370,000 | +$16M | 6.3% |
| Mimedx Group Inc | Exited | −1,300,000 | −$15.1M | — |
| Medtronic PLC | Added | +200,000 | +$13.4M | 5.6% |
| C Catamaran Corp | Exited | −189,802 | −$11.6M | — |
| TP Teva Pharmaceutical-sp ADR | New | +200,000 | +$11.3M | 1.3% |
Showing the 10 largest of 38 changes.
quarter ended June 30, 2015 · filed August 11, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust | Added | +200,000 | +$41.2M | 14.2% |
| PC Patterson Cos Inc | Added | +537,055 | +$26.1M | 4.8% |
| TP Teva Pharmaceutical-sp ADR | Exited | −400,000 | −$24.9M | — |
| BD Becton Dickinson & Co | Added | +171,000 | +$24.2M | 6.5% |
| Quest Diagnostics | Added | +300,000 | +$21.8M | 5.8% |
| Inogen Inc | Trimmed | −475,000 | −$21.2M | 0.4% |
| Dexcom Inc | Exited | −225,000 | −$14M | — |
| Pfizer Inc | Exited | −391,198 | −$13.6M | — |
| IR Ishares Russell 2000 | Added | +100,000 | +$12.5M | 7.2% |
| KB Keryx Biopharmaceuticals | Exited | −950,000 | −$12.1M | — |
Showing the 10 largest of 44 changes.
quarter ended March 31, 2015 · filed May 11, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust | New | +400,000 | +$82.6M | 10.9% |
| IR Ishares Russell 2000 | New | +400,000 | +$49.7M | 6.6% |
| SS SPDR S&P 500 ETF Trust | Trimmed | −200,000 | −$41.3M | 10.9% |
| IR Ishares Russell 2000 | Exited | −250,000 | −$29.9M | — |
| Medtronic PLC | New | +375,000 | +$29.2M | 3.9% |
| Medtronic Inc | Exited | −325,000 | −$23.5M | — |
| Pfizer Inc | Exited | −450,000 | −$14M | — |
| Quest Diagnostics | Trimmed | −180,000 | −$13.8M | 4.1% |
| Pfizer Inc | New | +391,198 | +$13.6M | 1.8% |
| Philip Morris International | Exited | −150,000 | −$12.2M | — |
Showing the 10 largest of 49 changes.
quarter ended December 31, 2014 · filed February 11, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Quest Diagnostics | New | +580,000 | +$38.9M | 5.9% |
| IR Ishares Russell 2000 | New | +250,000 | +$29.9M | 4.5% |
| C Carefusion Corp | Trimmed | −421,500 | −$25M | 0.7% |
| SS SPDR S&P 500 ETF Trust | Added | +100,000 | +$20.6M | 18.7% |
| AP Auxilium Pharmaceuticals Inc | Exited | −650,000 | −$19.4M | — |
| BD Becton Dickinson & Co | Added | +125,000 | +$17.4M | 3.5% |
| AM Allscripts Misys Healthcare Solutions In | New | +1,250,000 | +$16M | 2.4% |
| Mimedx Group Inc | Trimmed | −1,350,000 | −$15.6M | 1.1% |
| Inogen Inc | Added | +413,383 | +$13M | 3.2% |
| Dexcom Inc | Added | +235,000 | +$12.9M | 2.8% |
Showing the 10 largest of 38 changes.
quarter ended September 30, 2014 · filed November 07, 2014
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IR Ishares Russell 2000 | Exited | −1,100,000 | −$128M | — |
| SS SPDR S&P 500 ETF Trust | New | +500,000 | +$98.5M | 21.8% |
| Medtronic Inc | New | +370,000 | +$22.9M | 5.1% |
| CP Covidien PLC | Exited | −225,000 | −$20.5M | — |
| C Carefusion Corp | Trimmed | −375,000 | −$17M | 5.0% |
| V Volcano Corp | Trimmed | −1,518,300 | −$16.2M | 1.2% |
| C Catamaran Corp | Exited | −300,000 | −$13M | — |
| Philip Morris International | New | +150,000 | +$12.5M | 2.8% |
| Pfizer Inc | New | +400,000 | +$11.8M | 2.6% |
| AP Aegerion Pharmaceuticals Inc | Exited | −400,000 | −$11.7M | — |
Showing the 10 largest of 37 changes.
quarter ended June 30, 2014 · filed August 15, 2014
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IR Ishares Russell 2000 | Added | +900,000 | +$105M | 26.2% |
| SS SPDR S&P 500 ETF Trust | Exited | −350,000 | −$65.5M | — |
| IT Insys Therapeutics Inc | Exited | −477,141 | −$19.8M | — |
| Johnson & Johnson | Exited | −175,000 | −$17.2M | — |
| S Spectranetics Corp | Added | +625,000 | +$14.3M | 5.4% |
| E Endologix Inc | Added | +950,000 | +$13.4M | 6.9% |
| TP Teva Pharmaceutical-sp ADR | New | +246,500 | +$13.3M | 2.7% |
| AP Aegerion Pharmaceuticals Inc | New | +400,000 | +$11.7M | 2.4% |
| Ironwood Pharmaceuticals Inc | New | +800,000 | +$11.5M | 2.3% |
| BR Biomed Realty Trust Inc | Exited | −550,000 | −$11.3M | — |
Showing the 10 largest of 34 changes.
quarter ended March 31, 2014 · filed May 12, 2014
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Trust | Trimmed | −150,000 | −$28.1M | 16.3% |
| E Endologix Inc | New | +1,425,000 | +$18.3M | 4.6% |
| Johnson & Johnson | New | +175,000 | +$17.2M | 4.3% |
| A Allergan Inc | Exited | −125,000 | −$13.9M | — |
| VM Varian Medical Systems Inc | Exited | −165,000 | −$12.8M | — |
| IR Ishares Russell 2000 | Trimmed | −100,000 | −$11.6M | 5.8% |
| Dexcom Inc | Exited | −310,000 | −$11M | — |
| C Catamaran Corp | Added | +225,000 | +$10.1M | 3.6% |
| IT Insys Therapeutics Inc | Added | +242,141 | +$10M | 4.9% |
| C Carefusion Corp | Added | +240,000 | +$9.65M | 7.0% |
Showing the 10 largest of 31 changes.
Loading...
